Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Commun Biol. 2021 Aug 12;4(1):963. doi: 10.1038/s42003-021-02493-4.
Gene expression toxicity is an important biological phenomenon and a major bottleneck in biotechnology. Escherichia coli BL21(DE3) is the most popular choice for recombinant protein production, and various derivatives have been evolved or engineered to facilitate improved yield and tolerance to toxic genes. However, previous efforts to evolve BL21, such as the Walker strains C41 and C43, resulted only in decreased expression strength of the T7 system. This reveals little about the mechanisms at play and constitutes only marginal progress towards a generally higher producing cell factory. Here, we restrict the solution space for BL21(DE3) to evolve tolerance and isolate a mutant strain Evo21(DE3) with a truncation in the essential RNase E. This suggests that RNA stability plays a central role in gene expression toxicity. The evolved rne truncation is similar to a mutation previously engineered into the commercially available BL21Star(DE3), which challenges the existing assumption that this strain is unsuitable for expressing toxic proteins. We isolated another dominant mutation in a presumed substrate binding site of RNase E that improves protein production further when provided as an auxiliary plasmid. This makes it easy to improve other BL21 variants and points to RNases as prime targets for cell factory optimisation.
基因表达毒性是一种重要的生物学现象,也是生物技术的主要瓶颈。大肠杆菌 BL21(DE3) 是重组蛋白生产的最受欢迎选择,已经进化或工程改造了各种衍生品种,以促进提高产量和对毒性基因的耐受性。然而,以前进化 BL21 的努力,如 Walker 株 C41 和 C43,仅导致 T7 系统的表达强度降低。这揭示了很少有关发挥作用的机制,并构成了朝着更高产的细胞工厂的微不足道的进展。在这里,我们将 BL21(DE3) 的解决方案空间限制为进化耐受性,并分离出一种突变菌株 Evo21(DE3),其在必需的 RNase E 中存在截断。这表明 RNA 稳定性在基因表达毒性中起着核心作用。进化的 rne 截断类似于先前在市售 BL21Star(DE3)中设计的突变,这挑战了现有假设,即该菌株不适合表达毒性蛋白。我们在 RNase E 的假定底物结合位点中分离出另一个显性突变,当作为辅助质粒提供时,进一步提高了蛋白质产量。这使得改进其他 BL21 变体变得容易,并指出 RNases 是细胞工厂优化的主要目标。